Analysts Anticipate CME Group (CME) Will Announce Earnings of $1.85 Per Share

Equities analysts forecast that CME Group (NASDAQ:CME) will announce earnings per share of $1.85 for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for CME Group’s earnings. The highest EPS estimate is $1.86 and the lowest is $1.84. CME Group posted earnings of $1.22 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 51.6%. The business is expected to announce its next quarterly earnings report before the market opens on Thursday, April 26th.

On average, analysts expect that CME Group will report full year earnings of $6.86 per share for the current fiscal year, with EPS estimates ranging from $6.63 to $7.16. For the next fiscal year, analysts forecast that the firm will post earnings of $7.01 per share, with EPS estimates ranging from $6.87 to $7.20. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for CME Group.

How to Become a New Pot Stock Millionaire

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The firm had revenue of $900.00 million during the quarter, compared to analysts’ expectations of $886.85 million. During the same period in the previous year, the company earned $1.14 earnings per share. CME Group’s quarterly revenue was down 1.4% compared to the same quarter last year.

CME has been the subject of a number of research reports. Bank of America boosted their price target on shares of CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, February 2nd. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price target for the company in a research report on Tuesday, January 2nd. BidaskClub raised shares of CME Group from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, March 27th. Sandler O’Neill reissued a “buy” rating and issued a $175.00 price target on shares of CME Group in a research report on Friday, February 2nd. Finally, Barclays boosted their price target on shares of CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a research report on Friday, February 2nd. Three investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $165.57.

In other news, insider Derek Sammann sold 2,400 shares of the company’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $161.66, for a total value of $387,984.00. Following the completion of the sale, the insider now directly owns 40,153 shares of the company’s stock, valued at $6,491,133.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction dated Tuesday, April 10th. The shares were sold at an average price of $161.02, for a total transaction of $402,550.00. Following the completion of the sale, the chief financial officer now directly owns 34,957 shares of the company’s stock, valued at $5,628,776.14. The disclosure for this sale can be found here. Insiders sold 35,699 shares of company stock valued at $5,532,362 over the last ninety days. Corporate insiders own 0.57% of the company’s stock.

Several large investors have recently made changes to their positions in CME. ARK Investment Management LLC acquired a new position in shares of CME Group during the fourth quarter worth about $120,000. Valeo Financial Advisors LLC acquired a new position in shares of CME Group during the third quarter worth about $124,000. AlphaOne Investment Services LLC acquired a new position in shares of CME Group during the fourth quarter worth about $146,000. Mosaic Family Wealth LLC acquired a new position in shares of CME Group during the fourth quarter worth about $146,000. Finally, Truewealth LLC acquired a new position in shares of CME Group during the fourth quarter worth about $157,000. 83.41% of the stock is owned by institutional investors and hedge funds.

CME traded up $0.61 on Friday, reaching $165.08. The company had a trading volume of 1,589,375 shares, compared to its average volume of 1,743,985. CME Group has a 1 year low of $114.82 and a 1 year high of $171.71. The stock has a market cap of $56,231.60, a PE ratio of 34.61, a price-to-earnings-growth ratio of 2.29 and a beta of 0.56. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.03.

The firm also recently announced a quarterly dividend, which was paid on Monday, March 26th. Stockholders of record on Friday, March 9th were issued a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.70%. This is a boost from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date was Thursday, March 8th. CME Group’s dividend payout ratio is presently 58.70%.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Week Herald and is owned by of Week Herald. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://weekherald.com/2018/04/20/analysts-anticipate-cme-group-cme-will-announce-earnings-of-1-85-per-share.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply